Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Inspire Medical Systems (INSP) Stock Price & Analysis

815 Followers

INSP Stock Chart & Stats

$61.10$0.56(0.93%)
At close: 4:00 PM EST
$60$65$70$75Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
$60.12 - $61.47
52-Week Range
$38.91 - $147.03
Previous Close
$60.54
Volume
N/A
Average Volume (3M)
759.75K
Market Cap
$1.75B
Enterprise Value
$1.71B
Total Cash (Recent Filing)
$327.97M
Total Debt (Recent Filing)
$28.61M
Price to Earnings (P/E)
17.6
Beta
0.89
Next Earnings
Feb 09, 2027 (Est.)
EPS Estimate
0.92
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

High-margin, Differentiated Therapy

The 86% gross margin demonstrates strong economics for Inspire’s differentiated implantable therapy. Continued adoption of the higher-margin Inspire V system can support profitability and provide resources for clinical, commercial, and patient-access investments over the next several quarters.

Conservative Balance Sheet And Cash Generation

A debt-free balance sheet and substantial liquidity give Inspire flexibility to fund growth initiatives without relying heavily on external financing. Strong operating cash generation also improves resilience while the company manages reimbursement changes and invests in broader patient access.

Structural Reimbursement And Clinical Support

The approved Category I CPT code should simplify coding and reimbursement for Inspire V, reducing administrative friction for providers and patients. Combined with expanding clinical evidence, this can support physician adoption and improve access to the therapy over time.

Bears Say

Material Coding And Reimbursement Disruption

The estimated $120 million impact shows that reimbursement mechanics are materially affecting demand, provider behavior, and reported revenue. Until the billing environment fully stabilizes, these issues can delay procedures, reduce visibility, and pressure operating margins.

Near-term Revenue And Profitability Contraction

The simultaneous revenue decline and sharp reduction in adjusted operating income indicate meaningful operating deleverage. Lower volume or weaker procedure growth can therefore have an outsized effect on earnings, making execution and recovery in the core market important over the next several quarters.

Free Cash Flow Growth And Conversion Pressure

Although operating cash flow remains healthy, declining free cash flow growth and conversion below net income suggest that working-capital or reinvestment needs are absorbing more cash. This limits the portion of accounting profit available for durable reinvestment or financial flexibility.

Inspire Medical Systems News

INSP FAQ

What was Inspire Medical Systems’s price range in the past 12 months?
Inspire Medical Systems lowest stock price was $38.91 and its highest was $147.03 in the past 12 months.
What is Inspire Medical Systems’s market cap?
Inspire Medical Systems’s market cap is $1.75B.
When is Inspire Medical Systems’s upcoming earnings report date?
Inspire Medical Systems’s next earnings report is estimated for Feb 09, 2027 (not yet confirmed), which is in 87 days.
How were Inspire Medical Systems’s earnings last quarter?
Inspire Medical Systems released its earnings results on Nov 02, 2026. The company reported $0.14 earnings per share for the quarter, beating the consensus estimate of $0.087 by $0.053.
Is Inspire Medical Systems overvalued?
According to Wall Street analysts Inspire Medical Systems’s price is currently Undervalued.
Does Inspire Medical Systems pay dividends?
Inspire Medical Systems does not currently pay dividends.
What is Inspire Medical Systems’s EPS estimate?
Inspire Medical Systems’s EPS estimate is 0.92.
How many shares outstanding does Inspire Medical Systems have?
Inspire Medical Systems has 28,966,120 shares outstanding.
What happened to Inspire Medical Systems’s price movement after its last earnings report?
Inspire Medical Systems reported an EPS of $0.14 in its last earnings report, beating expectations of $0.087. Following the earnings report the stock price went down -7.901%.
Which hedge fund is a major shareholder of Inspire Medical Systems?
Hedge funds hold Inspire Medical Systems shares: the largest hedge-fund position in Inspire Medical Systems is 71,885,321 shares, and hedge funds decreased their holdings by 728.1K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology